Literature DB >> 3339502

Release of leukotriene C4 in respiratory tract during acute viral infection.

B Volovitz1, H Faden, P L Ogra.   

Abstract

Groups of children with wheezing during respiratory illness, children without wheezing during respiratory illness, and appropriately matched healthy children were tested for the presence and concentration of leukotriene C4 (LTC4) in nasopharyngeal secretions, employing the techniques of reverse-phase high-pressure liquid chromatography and radioimmunoassay. Although most wheezing children had LTC4 in nasopharyngeal secretions, the concentration of LTC4 among wheezing children who shed respiratory viruses was found to be consistently elevated (mean 1520 +/- 228 pg/0.1 mL) compared with values in wheezing children without evidence of viral infection (mean 709 +/- 147 pg/0.1 mL). In sharp contrast, little or no LTC4 activity was detected in healthy children (mean 106 +/- 77 pg/0.1 mL). These observations suggest that respiratory viruses are stimuli for the release of mediators of inflammation such as LTC4. Thus development of virus-induced bronchospasm may be related in part to direct mucosal cell-virus interaction and the release of pharmacologically active mediators in the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3339502     DOI: 10.1016/s0022-3476(88)80058-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

Review 1.  Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections.

Authors:  D Nadal; P L Ogra
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Why do viruses make infants wheeze?

Authors:  I M Balfour-Lynn
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

3.  Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus.

Authors:  Junyan Han; Yi Jia; Katsuyuki Takeda; Yoshiki Shiraishi; Masakazu Okamoto; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  2010-05-04       Impact factor: 21.405

Review 4.  Corticosteroid-sparing options in the treatment of childhood asthma.

Authors:  P J Helms
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 5.  Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection.

Authors:  N J Snell
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 6.  Acute and long-term effects of viral bronchiolitis in infancy.

Authors:  J F Price
Journal:  Lung       Date:  1990       Impact factor: 2.584

7.  The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.

Authors:  Neelam Sharma-Walia; Karthic Chandran; Kinjan Patel; Mohanan Valiya Veettil; Alexandru Marginean
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

8.  Epstein-Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4.

Authors:  J Gosselin; M Savard; M Tardif; L Flamand; P Borgeat
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 9.  Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

Authors:  J B Domachowske; H F Rosenberg
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 10.  Importance of respiratory viruses in acute otitis media.

Authors:  Terho Heikkinen; Tasnee Chonmaitree
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.